HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Girn, J. Articles by Chantler, J. Search for Related Content PubMed PubMed Citation Articles by Girn, J. Articles by Chantler, J. Agricola Articles by Girn, J. Articles by Chantler, J.

Enhancement of coxsackievirus B3 infection by antibody to a different coxsackievirus strain

Department of Pathology and Laboratory Medicine, University of British Columbia, #318, BCRICWH, 950 West 28th Avenue, Vancouver, British Columbia, CanadaV5Z 4H4¹

Author for correspondence: Janet Chantler. e-mail chantler{at}interchange.ubc.ca

Group B coxsackieviruses (CVBs) are a major cause of viral myocarditis and pancreatitis in humans and produce a similar pattern of disease in inbred strains of mice. As there are six strains of CVBs, individuals can be infected with multiple serotypes. This raises the possibility of antibody enhancement of infectivity (AEI) by cross-reactive but non-neutralizing antibody to a different strain from a prior infection. To determine whether AEI plays a role in coxsackievirus pathogenesis, an in vitro system using the murine macrophage cell line J774.1 was tested for enhanced infection when incubated with CVB3 plus anti-CVB2 antibody. Yields of virus were found to increase by 10–50-fold and the percentage of infected cells increased proportionately. The effect was Fc-mediated as F(ab')₂ fragments of the antibody could not mediate the effect. To determine whether AEI could also be demonstrated in vivo CVB3 was injected into 5-week-old mice together with mouse polyclonal anti-CVB2. Controls included mice injected with PBS or CVB3 alone. Results showed that the titres of virus in tissues of animals injected with virus plus antibody were 1–2 logs higher than when virus was injected alone. This was accompanied by greater histopathological damage, particularly in the heart. These results have implications for human disease as infection with multiple strains likely occurs during the lifetime of an individual.

This article has been cited by other articles:

				T.-C. Wu, Y.-F. Wang, Y.-P. Lee, J.-R. Wang, C.-C. Liu, S.-M. Wang, H.-Y. Lei, I.-J. Su, and C.-K. Yu Immunity to Avirulent Enterovirus 71 and Coxsackie A16 Virus Protects against Enterovirus 71 Infection in Mice J. Virol., October 1, 2007; 81(19): 10310 - 10315. [Abstract] [Full Text] [PDF]

				T. Joseph, M. T. Kibenge, and F. S. B. Kibenge Antibody-mediated growth of infectious salmon anaemia virus in macrophage-like fish cell lines J. Gen. Virol., July 1, 2003; 84(7): 1701 - 1710. [Abstract] [Full Text] [PDF]